KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Raw Materials (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 15 years of Raw Materials data on record, last reported at $273.2 million in Q4 2025.

  • For Q4 2025, Raw Materials fell 5.3% year-over-year to $273.2 million; the TTM value through Dec 2025 reached $273.2 million, down 5.3%, while the annual FY2025 figure was $273.2 million, 5.3% down from the prior year.
  • Raw Materials reached $273.2 million in Q4 2025 per ZBH's latest filing, down from $275.1 million in the prior quarter.
  • Across five years, Raw Materials topped out at $314.8 million in Q1 2024 and bottomed at $223.4 million in Q2 2022.
  • Average Raw Materials over 5 years is $276.0 million, with a median of $277.8 million recorded in 2021.
  • Peak YoY movement for Raw Materials: fell 20.07% in 2022, then skyrocketed 31.83% in 2023.
  • A 5-year view of Raw Materials shows it stood at $243.3 million in 2021, then grew by 7.4% to $261.3 million in 2022, then rose by 17.68% to $307.5 million in 2023, then fell by 6.18% to $288.5 million in 2024, then decreased by 5.3% to $273.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Raw Materials were $273.2 million in Q4 2025, $275.1 million in Q3 2025, and $278.2 million in Q2 2025.